Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 106Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Aimix

02 6Amlodin

03 1Caduet

04 4Exforge

05 4Exforge Group

06 8Norvasc

07 1Norvase

PharmaCompass

01

Brand Name : Amlodin

Amlodipine

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Amlodin

arrow
Medlab Asia & Asia Health
Not Confirmed

Amlodipine

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2020 Revenue in Millions : 65

2019 Revenue in Millions : 76

Growth (%) : -15

blank

02

Brand Name : Norvasc

Amlodipine

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Norvasc

arrow
Medlab Asia & Asia Health
Not Confirmed

Amlodipine

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2019 Revenue in Millions : 950

2018 Revenue in Millions : 1,029

Growth (%) : -8

blank

03

Brand Name : Exforge Group

Amlodipine

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Exforge Group

arrow
Medlab Asia & Asia Health
Not Confirmed

Amlodipine

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2020 Revenue in Millions : 980

2019 Revenue in Millions : 1,025

Growth (%) : -4

blank

04

Brand Name : Amlodin

Amlodipine

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Amlodin

arrow
Medlab Asia & Asia Health
Not Confirmed

Amlodipine

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2021 Revenue in Millions : 50

2020 Revenue in Millions : 65

Growth (%) : -12

blank

05

Brand Name : Exforge Group

Amlodipine

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Exforge Group

arrow
Medlab Asia & Asia Health
Not Confirmed

Amlodipine

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2021 Revenue in Millions : 901

2020 Revenue in Millions : 980

Growth (%) : -8

blank

06

Brand Name : Exforge Group

Amlodipine

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Exforge Group

arrow
Medlab Asia & Asia Health
Not Confirmed

Amlodipine

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2022 Revenue in Millions : 743

2021 Revenue in Millions : 901

Growth (%) : -18

blank

07

Brand Name : Norvasc

Amlodipine

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Norvasc

arrow
Medlab Asia & Asia Health
Not Confirmed

Amlodipine

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2022 Revenue in Millions : 775

2021 Revenue in Millions : 825

Growth (%) : -6

blank

08

Brand Name : Exforge Group

Amlodipine

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Exforge Group

arrow
Medlab Asia & Asia Health
Not Confirmed

Amlodipine

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2023 Revenue in Millions : 713

2022 Revenue in Millions : 743

Growth (%) : -4

blank

09

Brand Name : Norvasc

Amlodipine

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Norvasc

arrow
Medlab Asia & Asia Health
Not Confirmed

Amlodipine

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2023 Revenue in Millions : 732

2022 Revenue in Millions : 775

Growth (%) : -6

blank

10

Brand Name : Norvasc

Amlodipine

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Norvasc

Country
arrow
Medlab Asia & Asia Health
Not Confirmed

Amlodipine

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2020 Revenue in Millions : 601

2019 Revenue in Millions : 735

Growth (%) : -18

blank